Anagnostis P, Adamidou F, Polyzos S A, Efstathiadou Z, Panagiotou A, Kita M
Endocrinology Clinic, Hippokration Hospital, 49 Konstantinoupoleos str., Thessaloniki, Greece.
Exp Clin Endocrinol Diabetes. 2011 May;119(5):314-9. doi: 10.1055/s-0030-1267991. Epub 2011 Jan 24.
To describe the clinical imaging and hormonal characteristics and the natural course of patients with clinically non-functioning pituitary adenomas (NFPAs) presenting at our department from 1984 to 2009.
Retrospective review of electronic medical records of patients with NFPAs. The patients underwent basal and dynamic evaluation of the hypothalamic-pituitary axis. Size and functional alterations were estimated at yearly intervals.
114 patients (55 men and 59 women, aged 47±2) were studied. The mean follow-up time was 55±6 months (range 0-240). 45% of the adenomas were incidentally discovered and 75% were macroadenomas (73% with extrasellar extension). At diagnosis, 53% had headache and 76% of those with macroadenomas had visual field defects. Disruption of ≥1 pituitary axes was identified in 31% of patients at diagnosis. Surgery was performed in 59% and radiotherapy in 9% of the cases. 88% of surgically treated patients reported improvement in headache and 59% in visual fields. However, the prevalence of permanent diabetes insipidus increased from 2% at diagnosis to 15% postoperatively. The prevalence of ≥1 pituitary deficiencies and panhypopituitarism increased significantly postoperatively. 58% of the adenomas relapsed in size. 29% of the patients were managed conservatively and tumor size remained stable in 83% of them.
The majority of NFPAs not selected for surgery at diagnosis remained stable in size. Pituitary dysfunction and visual defects at diagnosis were common. Surgical debulking led to clinical improvement, but relapse occurred in 2/3 of the cases.
描述1984年至2009年在我院就诊的临床无功能垂体腺瘤(NFPAs)患者的临床影像学和激素特征以及自然病程。
对NFPAs患者的电子病历进行回顾性分析。患者接受下丘脑 - 垂体轴的基础和动态评估。每年评估肿瘤大小和功能变化。
共研究了114例患者(55例男性和59例女性,年龄47±2岁)。平均随访时间为55±6个月(范围0 - 240个月)。45%的腺瘤是偶然发现的,75%为大腺瘤(73%有鞍外扩展)。诊断时,53%的患者有头痛症状,76%的大腺瘤患者有视野缺损。诊断时31%的患者发现≥1条垂体轴功能紊乱。59%的病例进行了手术,9%的病例接受了放疗。88%接受手术治疗的患者报告头痛症状改善,59%的患者视野改善。然而,永久性尿崩症的患病率从诊断时的2%升至术后的15%。≥1种垂体功能减退和全垂体功能减退的患病率术后显著增加。58%的腺瘤大小复发。29%的患者接受保守治疗,其中83%的患者肿瘤大小保持稳定。
大多数诊断时未选择手术的NFPAs患者肿瘤大小保持稳定。诊断时垂体功能障碍和视野缺损很常见。手术切除肿瘤可使临床症状改善,但2/3的病例会复发。